Replies to post #380119 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Not before, but one of pre-specified analysis biomarkers of the P2b/3 AD trial.

Blood assessment [ Time Frame: 48 weeks ]
Blood assessment from baseline and compared to placebo at +48 weeks: Abeta40, Abeta42, T-tau, NFL, YKL-40, BACE1 concentration